Adaptive and Innate Cytotoxic Effectors in Chronic Lymphocytic Leukaemia (CLL) Subjects with Stable Disease
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24119596 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Valentina Rubino und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medical Sciences, University of Naples "Federico II", 80131 Naples, Italy. Hauptthemen laut MEDLINE: Leukemia, Lymphocytic, Chronic, B-Cell, Antineoplastic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero Italiano dell'Università e della Ricerca "Prodotti innovativi ad alto contenuto biotecnologico- INBIOMED", Ministero Italiano dell’Università e della Ricerca.
Abstract (Originalsprache)
Chronic lymphocytic leukaemia (CLL) is characterised by the expansion of a neoplastic mature B cell clone. CLL clinical outcome is very heterogeneous, with some subjects never requiring therapy and some showing an aggressive disease. Genetic and epigenetic alterations and pro-inflammatory microenvironment influence CLL progression and prognosis. The involvement of immune-mediated mechanisms in CLL control needs to be investigated. We analyse the activation profile of innate and adaptive cytotoxic immune effectors in a cohort of 26 CLL patients with stable disease, as key elements for immune-mediated control of cancer progression. We observed an increase in CD54 expression and interferon (IFN)-γ production by cytotoxic T cells (CTL). CTL ability to recognise tumour-targets depends on human leukocyte antigens (HLA)-class I expression. We observed a decreased expression of HLA-A and HLA-BC on B cells of CLL subjects, associated with a significant reduction in intracellular calnexin that is relevant for HLA surface expression. Natural killer (NK) cells and CTL from CLL subjects show an increased expression of the activating receptor KIR2DS2 and a reduction of 3DL1 and NKG2A inhibiting molecules. Therefore, an activation profile characterises CTL and NK cells of CLL subjects with stable disease. This profile is conceivable with the functional involvement of cytotoxic effectors in CLL control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Translational Medical Sciences, University of Naples "Federico II", 80131 Naples, Italy.
- Department of Science, University of Basilicata, 85100 Potenza, Italy.
- Division of Hematology, Department of Clinical Medicine and Surgery, University of Naples "Federico II", 80131 Naples, Italy.
ORCID-Profile: Valentina Rubino, Martina Calabrò, Rosangela Montanaro, Vincenzo Brancaleone, Fabrizio Pane, Giuseppina Ruggiero, Giuseppe Terrazzano
Förderung
- Ministero Italiano dell'Università e della Ricerca "Prodotti innovativi ad alto contenuto biotecnologico- INBIOMED"
- Ministero Italiano dell’Università e della Ricerca
Zitieren
APA
Rubino, V., Carriero, F., Palatucci, A. T., Giovazzino, A., Leone, S., Nicolella, V., Calabrò, M., Montanaro, R., Brancaleone, V., Pane, F., Chiurazzi, F., Ruggiero, G., & Terrazzano, G. (2023). Adaptive and Innate Cytotoxic Effectors in Chronic Lymphocytic Leukaemia (CLL) Subjects with Stable Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24119596
Vancouver
Rubino V, Carriero F, Palatucci AT, Giovazzino A, Leone S, Nicolella V, et al. Adaptive and Innate Cytotoxic Effectors in Chronic Lymphocytic Leukaemia (CLL) Subjects with Stable Disease. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24119596
BibTeX
@article{Rubino2023,
author = {Rubino, Valentina and Carriero, Flavia and Palatucci, Anna Teresa and Giovazzino, Angela and Leone, Stefania and Nicolella, Valerio and Calabrò, Martina and Montanaro, Rosangela and Brancaleone, Vincenzo and Pane, Fabrizio and Chiurazzi, Federico and Ruggiero, Giuseppina and Terrazzano, Giuseppe},
title = {Adaptive and Innate Cytotoxic Effectors in Chronic Lymphocytic Leukaemia (CLL) Subjects with Stable Disease},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24119596}
}
EUVIMED